MyAverix Finance
F · Healthcare
ACELRX PHARMACEUT. DL-01 (R5XA)
Drug Manufacturers - Specialty & Generic
ACELRX PHARMACEUT. DL-01 (R5XA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $32.98M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R5XA
ACELRX PHARMACEUT. DL-01 (R5XA) — FAQ
What is ACELRX PHARMACEUT. DL-01's market cap?
ACELRX PHARMACEUT. DL-01 (R5XA) has a reported market cap of $32.98M (data as of 2026-03-30).
What is R5XA's P/E ratio?
The price-to-earnings (P/E) ratio for ACELRX PHARMACEUT. DL-01 (R5XA) is 18.00 (data as of 2026-03-30).
Does ACELRX PHARMACEUT. DL-01 pay a dividend?
Dividend yield is not available in the current snapshot for ACELRX PHARMACEUT. DL-01 (R5XA). Check the MyAverix Finance app for the latest dividend data.
What sector is ACELRX PHARMACEUT. DL-01 in?
ACELRX PHARMACEUT. DL-01 (R5XA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is R5XA listed on?
R5XA is listed on F.
What is ACELRX PHARMACEUT. DL-01's net margin?
ACELRX PHARMACEUT. DL-01 (R5XA) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.